| 764338 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
751 Neo-X-Prime bispecific antibodies targeting CD40 and tumor antigens promote cross-presentation of tumor exosome-derived neoantigen and induce superior anti-tumor responses compared to CD40 mAb |
2021-11-01 |
10.1136/jitc-2021-sitc2021.751 |
Hagerbrand Karin, Levin Mattias, Schantz Laura Von, Varas Laura, Säll Anna, Deronic Adnan, Sundstedt Anette, Ljung Lill, Barchan Karin, Werchau Doreen, Rosén Anna, Nyesiga Barnabas, Lindqvist Eva, Thagesson Mia, Ellmark Peter |
| 764337 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
750 AK119, a CD73 targeting antibody with dual mechanism of action |
2021-11-01 |
10.1136/jitc-2021-sitc2021.750 |
Huang Zhaoliang, Pang Xinghua, Zhong Tingting, Jin Chunshan, Chen Na, He Xinrong, Xia Dennis, Jin Xiaoping, Wang Zhongmin, Xia Xu, Li Baiyong |
| 764336 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
748 Targeting vasoactive intestinal peptide receptor signaling in pancreatic ductal adenocarcinoma for enhanced anti-tumor response to checkpoint blockade |
2021-11-01 |
10.1136/jitc-2021-sitc2021.748 |
Ravindranathan Sruthi, Fnu Tenzin Passang, Li Jian Ming, Dhamsania Rohan, Ware Michael, Zaidi Mohammad, Wang Shuhua, Zhu Jingru, Cardenas Maria, Liu Yuan, Gumber Sanjeev, Robinson Brian, Majumdar Anish, Chandrakasan Shanmuganathan, Kissick Haydn, Frey Alan, Thomas Susan, El-Rayes Bassel, Lesinski Gregory, Waller Edmund |
| 764335 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
738 Intratumoral administration of alum-tethered engineered inflammatory cytokines safely elicits potent local and systemic immunity |
2021-11-01 |
10.1136/jitc-2021-sitc2021.738 |
Agarwal Yash, Wittrup K., Irvine Darrell |
| 764334 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
737 Inhibition of P21-activated kinase 4 (PAK4) reverts immune exclusion and restores anti-tumor immunity in the tumor microenvironment |
2021-11-01 |
10.1136/jitc-2021-sitc2021.737 |
Zhou Yu 'Jerry', Chu Gina, Hendrickson Eleanore, Gullo-Brown Johnni, Chavez Brandy, McAlpine Indrawan, Rui Eugene, Doran Shawn, Timofeevski Sergei, Heyen Jonathan, Kinong Jennifer, Tang Szu-Yu, Oyer Jon, Rayannavar Vinayak, Nager Andrew, Ching Keith, Shi Stephanie, Bhadra Rajarshi, Dillon Christopher, Gururajan Murali |
| 764333 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
593 PI3Kγδ inhibitor combined with radiation enhances the antitumor immune effect of PD-1 blockade in syngenic murine breast cancer model and humanized patient-derived xenograft model |
2021-11-01 |
10.1136/jitc-2021-sitc2021.593 |
Han MIn Guk, Jang Bum Sup, Kang Mi Hyun, Na Deukchae, Kim In Ah |
| 764332 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
592 ATR-mediated CD47 and PD-L1 upregulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.592 |
Hsieh Rodney Cheng-En, Krishnan Sunil, Wu Ren-Chin, Boda Akash, Liu Arthur, Winkler Michelle, Hsu Wen-Hao, Lin Steven, Hung Mien-Chie, Chan Li-Chuan, Bhanu Krithikaa, Srinivasamani Anupallavi, Azevedo Ricardo De, Chou Yung-Chih, Depinho Ronald, Gubin Matthew, Vilar-Sanchez Eduardo, Chen Chao-Hsien, Slay Ravaen, Jayaprakash Priyamvada, Hegde Shweta, Hartley Genevieve, Lea Spencer, Prasad Rishika, Morrow Brittany, Couillault Coline, Steiner Madeline, Wang Chun-Chieh, Venkatesulu Bhanu, Taniguchi Cullen, Kim Betty, Chen Junjie, Rudqvist Nils-Petter, Curran Michael |
| 764331 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
591 Survival rates in Stage IV melanoma patients treated with radiation and immunotherapy differ depending on age and radiation treatment site |
2021-11-01 |
10.1136/jitc-2021-sitc2021.591 |
Colonna Catherine, Vohra Nasreen, Burke Aiden, Peach Matthew, Ju Andrew |
| 764330 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
589 Enhancement of the anti-tumor effects of CD47 blockade in solid tumors by combination with targeted radioimmunotherapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.589 |
Pachhal Sagarika, Greer Emily, Hwang Jesse, Liang Qing, Chen Mary, Geoghegan Eileen, Kotanides Helen, Ludwig Dale, Beckford Denis |
| 764329 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
588 Caloric restriction sensitizes melanoma to anti-PD-1 immune checkpoint inhibition |
2021-11-01 |
10.1136/jitc-2021-sitc2021.588 |
Melucci Alexa, Qin Shuyang, Chacon Alexander, Jewell Rachel, Prieto Peter |
